Brief: CytoMed Therapeutics Says Malaysian Patent Granted For Its Licensed Allogeneic CAR-Gamma Delta T Cell Technology
29/01/2024 14:29
Jan 29 (Reuters) - CytoMed Therapeutics Ltd F98.F :
* CYTOMED THERAPEUTICS LTD - MALAYSIAN PATENT GRANTED FOR
CYTOMED
THERAPEUTICS’ LICENSED ALLOGENEIC CAR-GAMMA DELTA T CELL
TECHNOLOGY
Source text for Eikon: ID:n0001493152-24-004055
Further company coverage: F98.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CytoMed Therapeutics
See all newsBrief: Cytomed Therapeutics Limited Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Brief: Cytomed Therapeutics Refutes "Misleading" Claims & Reaffirms Clinical Progress
Brief: Cytomed Therapeutics Completes Acquisition Of T Cell Technology From Uk To Treat Cancers In China And India
Brief: CytoMed Therapeutics To Start Dose Level 2 In Angelica Trial Q3 2025
Brief: Cytomed Therapeutics Ltd Files For Mixed Shelf Of Up To $50 Million